Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Abildgaard

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Diagnosis of von Willebrand diseaseC F Abildgaard
California Medicine|March 1, 1970
The use of clotting-factor concentrates for the treatment of hemophiliaC F Abildgaard
Thrombosis and Haemostasis|October 1, 1991
Warning: Simplate II--lack of standardization in standardized bleeding time devices--replyC F Abildgaard
Seminars in Hematology|July 1, 1975
Current concepts in the management of hemophiliaC F Abildgaard
Advances in Pediatrics|January 1, 1984
Progress and problems in hemophilia and von Willebrand's diseaseC F Abildgaard
California Medicine|March 1, 1970
Recognition and treatment of intravascular coagulationC F Abildgaard
California Medicine|August 1, 1970
Preoperative screening for bleeding diathesisC F Abildgaard
Seminars in Hematology|April 1, 1991
Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial GroupC F Abildgaard
The New England Journal of Medicine|March 12, 1981
Hazards of prothrombin-complex concentrates in treatment of hemophiliaC F Abildgaard
Blood|May 1, 1974
Fletcher factor deficiency: family study and detectionC F Abildgaard, J Harrison
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Progress in Clinical and Biological Research|January 1, 1990
Diagnosis of von Willebrand diseaseC F Abildgaard
California Medicine|March 1, 1970
The use of clotting-factor concentrates for the treatment of hemophiliaC F Abildgaard
Thrombosis and Haemostasis|October 1, 1991
Warning: Simplate II--lack of standardization in standardized bleeding time devices--replyC F Abildgaard
Seminars in Hematology|July 1, 1975
Current concepts in the management of hemophiliaC F Abildgaard
Advances in Pediatrics|January 1, 1984
Progress and problems in hemophilia and von Willebrand's diseaseC F Abildgaard
California Medicine|March 1, 1970
Recognition and treatment of intravascular coagulationC F Abildgaard
California Medicine|August 1, 1970
Preoperative screening for bleeding diathesisC F Abildgaard
Seminars in Hematology|April 1, 1991
Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial GroupC F Abildgaard
The New England Journal of Medicine|March 12, 1981
Hazards of prothrombin-complex concentrates in treatment of hemophiliaC F Abildgaard
Blood|May 1, 1974
Fletcher factor deficiency: family study and detectionC F Abildgaard, J Harrison
Pageof 5